| ²é¿´: 2346 | »Ø¸´: 1 | |||
qing_zyqͳæ (СÓÐÃûÆø)
|
[½»Á÷]
×îÐÂÏûÏ¢£¬ÂÞ·úË¾ÌØÖйúÉêÇë³·»ØÁË£¿£¡ ÒÑÓÐ1È˲ÎÓë
|
|
CortellisÐÅÏ¢ÏÔʾ£¬¹úÄÚµÄÂÞ·úË¾ÌØÉêÇëÔÚ2015Äê5Ô³·»Ø£¡ CHINA Filings were submitted in China in December 2011 [1259210], [1289750]. By May 2015, the filing for roflumilast in China had been withdrawn [1660461]. ¸üÐÂÀúÊ·ÏÔʾ£º 19-May-2015 Development profile section source updates Regulatory: Added [1660461] Development status:company/indication/country trio status change Pre-registration to No Development Reported,China, Takeda Pharmaceuticals International GmbH, Chronic obstructive pulmonary disease, 15-MAY-15 ÕâôºÃµÄÆ·ÖÖ²»Ó¦¸Ã¾ÍÕâô³·»Ø°¡£¬ÈýÆÚÁÙ´²¶¼×öÍêÁË£» Õâ¸ö¸üÐÂÖ»ÊÇ˵Èý·½×´Ì¬¸Ä±ä£¬ºÜÃ÷ÏÔÊÇÓÉÔÄοÆÃ÷תµ½ÁËÎäÌÊÊӦ֢Ҳδ·¢Éú±ä»¯£¬ÎªºÎÒª³·»Ø£¿ ²»Ã÷ËùÒÔ°¡£¡ÓÐÈËÊÍÒÉô£¿ |
» ²ÂÄãϲ»¶
BL21(DE3)UV»òÕßË¿ÁÑÃ¹ËØÓÕµ¼Ìõ¼þÏ»áÊÍ·ÅDE3µÄÊɾúÌåÂð£¿
ÒѾÓÐ14È˻ظ´
±±¾©ÐºÍҽѧԺ½ÜÇà¿ÎÌâ×éÕÐÆ¸¿ÆÑÐÖúÀí
ÒѾÓÐ0È˻ظ´
Ò©ÎïѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ195È˻ظ´
±±¾©ÐºÍҽѧԺ½ÜÇà¿ÎÌâ×éÕÐÆ¸¿ÆÑÐÖúÀí
ÒѾÓÐ0È˻ظ´
ÇóÖúÖйúÒ©µä1995Äê°æ¡¢¶þ²¿
ÒѾÓÐ0È˻ظ´
ÔÚÏßÇóÖú£¬¼±£¡£¡£¡ÇëÎÊÄÄÀï¿ÉÒÔ×ö´ÅÐÔÄÉÃײÄÁϵĸ߷ֱæÍ¸Éäµç¾µµÄ²âÊÔ±íÕ÷ѽ£¿
ÒѾÓÐ5È˻ظ´
±±¾©ÐºÍҽѧԺ½ÜÇà¿ÎÌâ×éÕÐÆ¸¿ÆÑÐÖúÀí
ÒѾÓÐ0È˻ظ´
¸£ÖÝ´óѧÀîÐËÊç½ÌÊÚ¿ÎÌâ×é¼±Õв©Ê¿Ñо¿Éú
ÒѾÓÐ9È˻ظ´
Liquid Chromatography-Mass Spectrometry Analysis of Small Interfering RNAs
ÒѾÓÐ1È˻ظ´
ÇóÖúhttps://www.pnas.org/doi/10.1073/pnas.2535777123 È«ÎÄ
ÒѾÓÐ0È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
ÂÞ·úË¾ÌØ£¬ÔÓÖÊÑо¿
ÒѾÓÐ17È˻ظ´
ÂÞ·úË¾ÌØ£¨roflumilast£©µÄºÏ³É--¼æ»Øhanyu0901
ÒѾÓÐ157È˻ظ´

bluelilycl
ľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 3 (Ó×¶ùÔ°)
- ½ð±Ò: 4631.1
- É¢½ð: 180
- ºì»¨: 1
- ɳ·¢: 1
- Ìû×Ó: 980
- ÔÚÏß: 154.8Сʱ
- ³æºÅ: 1968455
- ×¢²á: 2012-09-02
- רҵ: Ò©Îï·ÖÎö
2Â¥2022-08-11 14:18:06











»Ø¸´´ËÂ¥
10